In this article, we catch up with the past. Just to make sure that we have everyone on the same virtual page. Acomplia (generic name rimonabant) has been an authorised medication in the EU since June 2006 for use in …

Acomplia produced disappointing results in slowing progression of coronary artery disease in patients and it significantly raised the risk of anxiety and depression, according to a report in the April 2 issue of the Journal of the American Medical Association.
More …